Skip to content
Research Article Open access CC BY 4.0

“Modifiable Hyperkalemia with Timely Recognition”- Beta Blocker (Metoprolol succinate) induced

Prasanth Prasad, Sumesh Raj

Asian Journal of Research in Medical and Pharmaceutical Sciences · pp. 12–14 · Published 15 Jul 2022

10.9734/ajrimps/2022/v11i330190

Abstract

This case report describes the very rarest possibility of drug induced hyperkalemia with beta blockers. In literature search only 2 cases were reported as metoprolol succinate induced hyperkalemia in diabetes patients without renal insufficiency. As per FDA reports  only 0.5 % patients have reported hyperkalemia induced by metoprolol [1]. Patient is diabetic and hypertensive. And she is on oral hypoglycemic agents, premixed insulin and on beta blockers along with calcium channel blocker. The potassium value was ranging from 6 to 6.7 mmol/l. Evaluated in detail and no other abnormalities noted in laboratory investigations. Once the offending drug metoprolol is withdrawn the potassium value reaches to normal range in very short period.

Metoprolol succinate hyperkalemia betablocker induced

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.